查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1625252

2030 年生医光电市场预测：按技术、应用、最终用户和地区进行的全球分析

Biophotonics Market Forecasts to 2030 - Global Analysis By Technology (In-vivo and In-vitro), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2024年全球生医光电市场规模为760.8亿美元，预计在预测期内将以12.2%的复合年增长率增长，到2030年达到1517.9亿美元。

生医光电是生物学和医学中基于光的技术的研究和应用。光用于理解和操纵细胞、组织和器官等生物系统。这个跨学科领域结合了物理学、生物学和工程学的原理，发展出影像、诊断、治疗和治疗的工具。萤光显微镜、光学相干断层扫描和雷射治疗等技术在生医光电中很常见，促进了医学影像、疾病检测和标靶治疗等领域的进步。

政府支持和资金筹措

政府机构的资助通常会加速新生医光电技术的开发，并实现医学诊断、影像和治疗方面的突破。津贴、补贴和税收优惠鼓励私人公司投资生医光电并降低与开发新技术相关的财务风险。此外，公共资金支持大学、研究机构和产业领导者之间的合作，以加速生医光电产品的商业化。旨在推动医疗保健和医疗设备的政府倡议将进一步推动临床和实验室环境中生医光电应用的需求。这种全面的支援不仅推动市场成长，还确保最尖端科技融入主流医疗保健解决方案。

技术限制

将光电与生物系统整合非常复杂，并对准确性和可靠性提出了挑战。先进生医光电技术的高成本限制了其在研究和临床应用中的应用。设备之间缺乏标准化和互通性阻碍了与现有医疗保健基础设施的无缝整合。此外，影像系统有限的灵敏度和解析度妨碍了准确的诊断和治疗监测。最后，操作生医光电工具所需的专门训练和专业知识也是广泛使用的障碍。

扩大再生医学的应用

在组织再生中使用基于光的技术，例如基于雷射的治疗和成像技术，正在提高治疗的精度和有效性。生医光电可以更好地可视化和监测细胞过程，这对于开发新的再生疗法至关重要。随着干细胞研究和基因治疗的进步，生医光电工具对于追踪细胞行为和组织再生至关重要。对非侵入性诊断工具的需求也促进了再生医学中生医光电的发展。随着再生医学的不断发展，生医光电在实现突破性治疗和改善患者治疗效果方面发挥关键作用。

隐私和资料安全问题

透过生医光电应用产生的医疗资料高度敏感，引发了对未授权存取和滥用的担忧。 GDPR 等严格法规要求生医光电公司在安全系统上投入大量资金，增加了营运成本。资料保护措施不足可能会导致资讯洩露，损害公司的声誉和信誉。消费者不愿共用个人健康资讯将进一步减缓生医光电技术的采用。因此，这些担忧正在减缓创新生医光电解决方案在医疗诊断和治疗中的采用。

COVID-19 的影响

COVID-19 大流行对生医光电市场产生了重大影响，扰乱了製造、供应链和研究活动。然而，生医光电在医疗保健领域的采用，特别是诊断和治疗应用，也在加速。对快速、非侵入性测试（例如 COVID-19 检测和监测）的需求不断增长，推动了光学生物感测器和成像系统的创新。儘管早期遭遇挫折，但随着全球医疗保健技术投资的增加，这场大流行凸显了生医光电在医疗诊断中的重要性，并提振了该行业的长期成长前景。

预计体内细分市场在预测期内将是最大的

透过实现生物过程的即时成像和监测，体内领域有望实现利润丰厚的成长。组织、细胞和器官的非侵入性高解析度视觉化提高了诊断准确性和治疗监测。对个人化医疗和早期疾病检测日益增长的需求进一步推动了体内生医光电的采用。此外，其在药物发现和临床前测试中的应用提高了药物开发的效率和成功率，成为市场发展的驱动力。随着研究投资的增加和医疗保健领域的进步，体内领域继续塑造生医光电市场的未来。

预计医疗领域在预测期内复合年增长率最高

由于先进的诊断和治疗方法，预计医疗治疗领域在预测期内将出现最高的复合年增长率。生医光电促进了光学相干断层扫描 (OCT) 等非侵入性成像技术，以增强疾病检测和监测。生医光电也支持标靶治疗并提高癌症和其他疾病的治疗精度。此外，雷射技术的创新可以实现更有效的手术和更短的恢復时间。随着医疗保健需求的发展，医疗产业对生医光电学来改善患者照护的依赖不断扩大，刺激了市场成长。

比最大的地区

由于医疗保健、农业和环境领域的进步，预计亚太地区在预测期内将占据最大的市场占有率。对影像和光谱等诊断技术的需求不断增长，加上慢性病盛行率的上升，正在推动市场的发展。该地区的生物技术和医疗设备产业进一步推动了生医光电的需求。中国、日本和印度等国家正大力投资研发，以促进治疗和诊断应用的创新。

复合年增长率最高的地区：

由于医疗诊断、治疗和研究应用的进步，预计北美在预测期内将出现最高的复合年增长率。关键技术包括光学相干断层扫描（OCT）、萤光成像和拉曼光谱，广泛应用于癌症检测、药物传输、组织分析等领域。该地区受益于强大的医疗基础设施、大量的研发投资以及对非侵入性诊断技术的高需求。美国和加拿大的领先公司正在投资创新解决方案以推动成长。政府的倡议，加上医疗保健意识的提高，正在进一步推动北美市场的扩张。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球生医光电市场：依技术分类

  • 体内
  • 试管内

第六章全球生医光电市场：依应用分类

  • 透视成像
  • 内部影像
  • 光谱分子
  • 表面成像
  • 显微镜检查
  • 光疗
  • 分析感测
  • 生物感测器
  • 其他用途

第七章全球生医光电市场：依最终用户分类

  • 医学诊断
  • 治疗
  • 测试和组件
  • 非医疗用途
  • 其他最终用户

第八章全球生医光电市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、合作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十章 公司概况

  • Thermo Fisher Scientific Inc.
  • Carl Zeiss AG
  • Horiba Ltd.
  • Olympus Corporation
  • Abcam Plc
  • Biolitec AG
  • Agilent Technologies Inc.
  • Sartorius AG
  • Lumenis Ltd.
  • PerkinElmer Inc.
  • LightLab Imaging, Inc.
  • Medtronic Plc
  • Photonis Technologies
  • Nikon Corporation
  • Beckman Coulter, Inc.
Product Code: SMRC28207

According to Stratistics MRC, the Global Biophotonics Market is accounted for $76.08 billion in 2024 and is expected to reach $151.79 billion by 2030 growing at a CAGR of 12.2% during the forecast period. Biophotonics is the study and application of light-based technologies in biological and medical sciences. It involves using light to understand and manipulate biological systems, such as cells, tissues, and organs. This interdisciplinary field combines principles from physics, biology, and engineering to develop tools for imaging, diagnosis, therapy, and treatment. Techniques like fluorescence microscopy, optical coherence tomography, and laser-based therapies are common in biophotonics, enabling advancements in areas such as medical imaging, disease detection, and targeted treatments.

Market Dynamics:

Driver:

Government support and funding

Financial backing from government agencies often accelerates the development of new biophotonic technologies, enabling breakthroughs in medical diagnostics, imaging, and therapy. Grants, subsidies, and tax incentives encourage private companies to invest in biophotonics, reducing the financial risks associated with developing novel technologies. Additionally, public funding supports collaborations between universities, research institutions, and industry leaders, facilitating the commercialization of biophotonic products. Government initiatives aimed at advancing healthcare and medical devices further drive demand for biophotonic applications in clinical and laboratory settings. This collective support not only stimulates market growth but also ensures the integration of cutting-edge technologies into mainstream healthcare solutions.

Restraint:

Technical limitations

Complexities in integrating photonics with biological systems create challenges in precision and reliability. High costs associated with advanced biophotonics technologies restrict their widespread adoption in research and clinical applications. The lack of standardization and interoperability between devices hampers seamless integration into existing healthcare infrastructures. Additionally, limitations in the sensitivity and resolution of imaging systems prevent accurate diagnostics and therapeutic monitoring. Finally, the need for specialized training and expertise to operate biophotonics tools adds another barrier to widespread implementation.

Opportunity:

Expanding applications in regenerative medicine

The use of light-based technologies in tissue regeneration, such as laser-based therapies and imaging techniques, is enhancing the precision and effectiveness of medical treatments. Biophotonics enables better visualization and monitoring of cellular processes, which is critical in developing new regenerative therapies. With advances in stem cell research and gene therapy, biophotonics tools are essential for tracking cellular behavior and tissue regeneration. The demand for non-invasive diagnostic tools also contributes to the growth of biophotonics in regenerative medicine. As regenerative medicine continues to evolve, biophotonics plays a crucial role in enabling groundbreaking therapies and improving patient outcomes.

Threat:

Privacy and data security concerns

The sensitive nature of medical data generated through biophotonics applications raises fears of unauthorized access and misuse. Stringent regulations, such as GDPR, require biophotonics companies to invest heavily in secure systems, adding to operational costs. Inadequate data protection measures can lead to potential breaches, harming a company's reputation and credibility. Consumer reluctance to share personal health information further slows adoption of biophotonics technologies. Consequently, these concerns delay the widespread implementation of innovative biophotonics solutions in medical diagnostics and treatment.

Covid-19 Impact

The Covid-19 pandemic significantly impacted the biophotonics market, with disruptions in manufacturing, supply chains, and research activities. However, it also accelerated the adoption of biophotonics in healthcare, particularly for diagnostic and therapeutic applications. Increased demand for rapid, non-invasive testing, such as for Covid-19 detection and monitoring, drove innovations in optical biosensors and imaging systems. Despite initial setbacks, the pandemic highlighted the importance of biophotonics in medical diagnostics, boosting long-term growth prospects in the sector as investment in healthcare technologies increased globally.

The in-vivo segment is expected to be the largest during the forecast period

The in-vivo segment is estimated to have a lucrative growth, by enabling real-time imaging and monitoring of biological processes. It allows for non-invasive, high-resolution visualization of tissues, cells, and organs, enhancing diagnostic accuracy and treatment monitoring. The growing demand for personalized medicine and early disease detection further fuels the adoption of in-vivo biophotonics. Additionally, its applications in drug discovery and pre-clinical studies drive market growth by improving the efficiency and success rates of pharmaceutical developments. With increasing research investments and healthcare advancements, the in-vivo segment continues to shape the future of the Biophotonics market.

The medical therapeutic segment is expected to have the highest CAGR during the forecast period

The medical therapeutic segment is anticipated to witness the highest CAGR growth during the forecast period, due to advanced diagnostic and treatment methods. It facilitates non-invasive imaging techniques, such as optical coherence tomography (OCT), which enhances disease detection and monitoring. Biophotonics also supports targeted therapies, improving the precision of treatments for conditions like cancer. Additionally, innovations in laser technologies allow for more effective surgeries with faster recovery times. As healthcare demands evolve, the medical sector's reliance on biophotonics for improved patient care continues to expand, stimulating market growth.

Region with largest share:

Asia Pacific is expected to hold the largest market share during the forecast period by advancements in healthcare, agriculture, and environmental sectors. Increasing demand for diagnostic technologies, such as imaging and spectroscopy, coupled with the rising prevalence of chronic diseases, is propelling the market. The region's booming biotechnology and medical device industries further contribute to the demand for biophotonics. Countries like China, Japan, and India are at the forefront, with substantial investments in research and development, fostering innovation in therapeutic and diagnostic applications.

Region with highest CAGR:

North America is expected to have the highest CAGR over the forecast period, owing to advancements in medical diagnostics, therapeutics, and research applications. Key technologies include optical coherence tomography (OCT), fluorescence imaging, and Raman spectroscopy, widely used in cancer detection, drug delivery, and tissue analysis. The region benefits from a robust healthcare infrastructure, substantial investments in research and development, and a high demand for non-invasive diagnostic techniques. Leading players in the U.S. and Canada are investing in innovative solutions, fostering growth. Government initiatives, coupled with increasing healthcare awareness, further support the market's expansion in North America.

Key players in the market

Some of the key players profiled in the Biophotonics Market include Thermo Fisher Scientific Inc., Carl Zeiss AG, Horiba Ltd., Olympus Corporation, Abcam Plc, Biolitec AG, Agilent Technologies Inc., Sartorius AG, Lumenis Ltd., PerkinElmer Inc. and LightLab Imaging, Inc.

Key Developments:

In November 2024, Carl Zeiss Meditec AG entered a strategic partnership with the Singapore Eye Research Institute (SERI). This collaboration focuses on improving surgical outcomes in refractive and cataract surgeries, with a funding commitment under Singapore's Research, Innovation and Enterprise.

In January 2024, Thermo Fisher announced a strategic collaboration with Galapagos NV for decentralized CAR-T manufacturing in the San Francisco area. This agreement includes providing GMP manufacturing and logistics services for Galapagos' CAR-T clinical program, marking a significant step in expanding their decentralized manufacturing strategy.

In July 2023, Carl Zeiss entered a long-term strategic partnership with the European Molecular Biology Laboratory (EMBL). This collaboration is focused on advancing research in molecular biology through innovative imaging technologies.

Technologies Covered:

  • In-vivo
  • In-vitro

Applications Covered:

  • See-through Imaging
  • Inside Imaging
  • Spectro Molecular
  • Surface Imaging
  • Microscopy
  • Light Therapy
  • Analytical Sensing
  • Biosensors
  • Other Applications

End Users Covered:

  • Medical Diagnostics
  • Medical Therapeutic
  • Tests & Components
  • Nonmedical Application
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biophotonics Market, By Technology

  • 5.1 Introduction
  • 5.2 In-vivo
  • 5.3 In-vitro

6 Global Biophotonics Market, By Application

  • 6.1 Introduction
  • 6.2 See-through Imaging
  • 6.3 Inside Imaging
  • 6.4 Spectro Molecular
  • 6.5 Surface Imaging
  • 6.6 Microscopy
  • 6.6 Light Therapy
  • 6.8 Analytical Sensing
  • 6.9 Biosensors
  • 6.10 Other Applications

7 Global Biophotonics Market, By End User

  • 7.1 Introduction
  • 7.2 Medical Diagnostics
  • 7.3 Medical Therapeutic
  • 7.4 Tests & Components
  • 7.5 Nonmedical Application
  • 7.6 Other End Users

8 Global Biophotonics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Thermo Fisher Scientific Inc.
  • 10.2 Carl Zeiss AG
  • 10.3 Horiba Ltd.
  • 10.4 Olympus Corporation
  • 10.5 Abcam Plc
  • 10.6 Biolitec AG
  • 10.7 Agilent Technologies Inc.
  • 10.8 Sartorius AG
  • 10.9 Lumenis Ltd.
  • 10.10 PerkinElmer Inc.
  • 10.11 LightLab Imaging, Inc.
  • 10.12 Medtronic Plc
  • 10.13 Photonis Technologies
  • 10.14 Nikon Corporation
  • 10.15 Beckman Coulter, Inc.

List of Tables

  • Table 1 Global Biophotonics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 3 Global Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
  • Table 4 Global Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
  • Table 5 Global Biophotonics Market Outlook, By Application (2022-2030) ($MN)
  • Table 6 Global Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
  • Table 7 Global Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
  • Table 8 Global Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
  • Table 9 Global Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
  • Table 10 Global Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
  • Table 11 Global Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
  • Table 12 Global Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
  • Table 13 Global Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
  • Table 14 Global Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 15 Global Biophotonics Market Outlook, By End User (2022-2030) ($MN)
  • Table 16 Global Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
  • Table 17 Global Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
  • Table 18 Global Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
  • Table 19 Global Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
  • Table 20 Global Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 21 North America Biophotonics Market Outlook, By Country (2022-2030) ($MN)
  • Table 22 North America Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 23 North America Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
  • Table 24 North America Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
  • Table 25 North America Biophotonics Market Outlook, By Application (2022-2030) ($MN)
  • Table 26 North America Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
  • Table 27 North America Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
  • Table 28 North America Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
  • Table 29 North America Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
  • Table 30 North America Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
  • Table 31 North America Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
  • Table 32 North America Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
  • Table 33 North America Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
  • Table 34 North America Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 35 North America Biophotonics Market Outlook, By End User (2022-2030) ($MN)
  • Table 36 North America Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
  • Table 37 North America Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
  • Table 38 North America Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
  • Table 39 North America Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
  • Table 40 North America Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 41 Europe Biophotonics Market Outlook, By Country (2022-2030) ($MN)
  • Table 42 Europe Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 43 Europe Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
  • Table 44 Europe Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
  • Table 45 Europe Biophotonics Market Outlook, By Application (2022-2030) ($MN)
  • Table 46 Europe Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
  • Table 47 Europe Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
  • Table 48 Europe Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
  • Table 49 Europe Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
  • Table 50 Europe Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
  • Table 51 Europe Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
  • Table 52 Europe Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
  • Table 53 Europe Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
  • Table 54 Europe Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 55 Europe Biophotonics Market Outlook, By End User (2022-2030) ($MN)
  • Table 56 Europe Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
  • Table 57 Europe Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
  • Table 58 Europe Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
  • Table 59 Europe Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
  • Table 60 Europe Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 61 Asia Pacific Biophotonics Market Outlook, By Country (2022-2030) ($MN)
  • Table 62 Asia Pacific Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 63 Asia Pacific Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
  • Table 64 Asia Pacific Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
  • Table 65 Asia Pacific Biophotonics Market Outlook, By Application (2022-2030) ($MN)
  • Table 66 Asia Pacific Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
  • Table 67 Asia Pacific Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
  • Table 68 Asia Pacific Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
  • Table 69 Asia Pacific Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
  • Table 70 Asia Pacific Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
  • Table 71 Asia Pacific Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
  • Table 72 Asia Pacific Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
  • Table 73 Asia Pacific Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
  • Table 74 Asia Pacific Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 75 Asia Pacific Biophotonics Market Outlook, By End User (2022-2030) ($MN)
  • Table 76 Asia Pacific Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
  • Table 77 Asia Pacific Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
  • Table 78 Asia Pacific Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
  • Table 79 Asia Pacific Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
  • Table 80 Asia Pacific Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 81 South America Biophotonics Market Outlook, By Country (2022-2030) ($MN)
  • Table 82 South America Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 83 South America Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
  • Table 84 South America Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
  • Table 85 South America Biophotonics Market Outlook, By Application (2022-2030) ($MN)
  • Table 86 South America Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
  • Table 87 South America Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
  • Table 88 South America Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
  • Table 89 South America Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
  • Table 90 South America Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
  • Table 91 South America Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
  • Table 92 South America Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
  • Table 93 South America Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
  • Table 94 South America Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 95 South America Biophotonics Market Outlook, By End User (2022-2030) ($MN)
  • Table 96 South America Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
  • Table 97 South America Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
  • Table 98 South America Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
  • Table 99 South America Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
  • Table 100 South America Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 101 Middle East & Africa Biophotonics Market Outlook, By Country (2022-2030) ($MN)
  • Table 102 Middle East & Africa Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 103 Middle East & Africa Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
  • Table 104 Middle East & Africa Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
  • Table 105 Middle East & Africa Biophotonics Market Outlook, By Application (2022-2030) ($MN)
  • Table 106 Middle East & Africa Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
  • Table 107 Middle East & Africa Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
  • Table 108 Middle East & Africa Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
  • Table 109 Middle East & Africa Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
  • Table 110 Middle East & Africa Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
  • Table 111 Middle East & Africa Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
  • Table 112 Middle East & Africa Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
  • Table 113 Middle East & Africa Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
  • Table 114 Middle East & Africa Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 115 Middle East & Africa Biophotonics Market Outlook, By End User (2022-2030) ($MN)
  • Table 116 Middle East & Africa Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
  • Table 117 Middle East & Africa Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
  • Table 118 Middle East & Africa Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
  • Table 119 Middle East & Africa Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
  • Table 120 Middle East & Africa Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)